ÔÚÂý²¡ÓÃÒ©¡¢¹ÜÀíµÈ·½Ã棬ÎÒ¹ú¾ÓÃñÈÔÈ»¸ü¶àµÄ½ÓÄÉ´«Í³ÓÃÒ©·½Ê½£¬ÔÚÒ©Æ·ÖÖÀà¡¢Ò©Æ·ÓÃÁ¿µÈ·½Ãæ½ÓÄÉͬһ»¯µÄģʽ£¬ÓÉ´ËÒý·¢µÄÒ©Îï²»Á¼·´Ó³Ô½À´Ô½³ÉΪÂý²¡ÓÃÒ©ÃæÁÙµÄÖ÷ÒªÁÙ´²ÎÊÌâ¡£¾Ý¡¶2023ÄêÊÀ½çÎÀÉúͳ¼Æ³ÂËß¡·ÏÔʾ£ºÂý²¡ÒѳÉΪȫÇò×î´óµÄ¼²²¡¸ºµ££¬Ô¤·À¡¢¿ØÖÆ¡¢¹ÜÀíÕâЩÂý²¡ÊÇ21ÊÀ¼ÍµÄµ±ÎñÖ®¼±¡£
ͼƬÀ´Ô´£ºCan J Cardiol Vol 23 No 12 October 2007.
Ò»¡¢Âý²¡¸öÌ廯ÓÃÒ©
ÓÐÊý¾ÝÏÔʾÿÄêÖÖÖÖÒòËص¼ÖµĽü1030ÍòËÀÍöÖУ¬ÂýÐÔ²¡Õ¼±È³¬80%£»ÐÄÄÔѪ¹Ü¡¢Ö×Áö¡¢ÌÇÄò²¡·¢²¡ÂʳÊÉÏÉýÇ÷ÊÆ£¬Ä¿Ç°Èý¸ßÈËȺÊýÁ¿Áè¼Ý6ÒÚ¡£ÒòÈý¸ßÒý·¢µÄÄÔ×äÖС¢ÐĹ£·ºÆð¸ß·¢²¡ÂÊ¡¢¸ßÖ²ÐÂÊ¡¢¸ßËÀÍöÂʵÄÏÖÏó£»µ¼Ö¼«Öصľ¼Ã¡¢Éç»á¸ºµ££¬¼«µÍµÄÉú»îÖÊÁ¿¡£Òò´ËÈçºÎ×ÊÖúÒ½ÉúÓÅ»¯ÓÃÒ©´¦·½¡¢¼õÉÙÒ©Îï²»Á¼·´Ó³¡¢ºÏÀíÄþ¾²ÓÃÒ©µÈÒѳÉΪÂý²¡¸öÌ廯¹ÜÀíÖØÖÐÖ®ÖØ¡£
ͼƬÀ´Ô´£ºÖйú¾ÓÃñÓªÑøÓëÂýÐÔ²¡×´¿ö³ÂËߣ¨2020Ä꣩£»È«¹úÖ×Áö¹ÒºÅÖÐÐÄ
Ò©Îï»ùÒò×éѧ(Pharmacogenomics, PGX)ÊÇÑо¿¸öÌå»ùÒò×éÐÅÏ¢ÓëÒ©ÎïÏìÓ¦¹ØϵµÄѧ¿Æ£¬Í¨¹ýÒ©Îï»ùÒò×éѧ¿ÉÒÔ×ÊÖúÒ½ÉúÓÅ»¯ÓÃÒ©´¦·½£¬ÒÔʵÏÖÌá¸ßÒ©ÎïÖÎÁÆЧ¹û¡¢½µµÍÒ©ÎﶾÐԺͲ»Á¼·´Ó³¼¸ÂÊ£¬×îÖÕµ½´ïÌá¸ßÒ½ÁÆЧÂʺÍÄþ¾²ÐÔ£¬½µµÍÒ½ÁÆÓöȵÄÄ¿µÄ¡£
ÔÚÈËȺÖвîÒì¸öÌå¼ä¶ÔÒ©ÎïµÄ·´Ó³¡¢¶¾ÐÔºÍÖÎÁÆЧӦ´æÔÚןܴóµÄ²îÒ죬·¢ÉúÕâÖÖ¸öÌå²îÒìµÄÔÒòÓкܶ࣬È综ÕßµÄÄêÁä¡¢ÐԱ𡢲¡³Ì½øÕ¹¡¢ÐÄÀí״̬µÈ¡£ÆäÖÐÒÅ´«ÒòËØ£¬¼´Ò©Îï´úлø¡¢×ªÔËÌåºÍÒ©Îï×÷Óðе㣨ÈçÊÜÌ壩µÄÒÅ´«¶à̬ÐÔÊÇÒ»¸öÖØÒªµÄÓ°ÏìÒòËØ¡£²îÒì¸öÌå¼äÒ©Îï´úлÏà¹ØÎïÖÊÒÅ´«¶à̬ÐԵĴæÔÚ£¬¿ÉÄܵ¼ÖÂÏàÓ¦Ò©ÎïÔÚÖÎÁÆÖзºÆðҩЧºÍ²»Á¼·´Ó³µÄ¸öÌå²îÒì¡£
ÒÔCYP2C19ΪÀý£¬¸ÃøΪ¸ÎÔàÖÐÒ»ÖÖÖØÒªµÄÒ©Îï´úлø£¬¾ßÓлùÒò¶à̬ÐÔ£¬CYP2C19»ùÒò¼ì²â¿É×ÊÖúÁÙ´²ÅжϾÓÉCYP2C19´úлµÄÒ©ÎïÔÚÌåÄڵĴúлËٶȣ¨¿ì¡¢ÖС¢Âý£©£¬´Ó¶øÌôÑ¡ºÏÊʵÄÒ©ÎѡÔñºÏÊʵļÁÁ¿£¬Ìá¸ßÒ©ÎïµÄÁÆЧ²¢½µµÍ²»Á¼·´Ó³¡£
ͼƬÀ´Ô´£ºKuo CH et al . CYP2C19 polymorphism influences eradication of H. pylori
¶þ¡¢Ö¸ÄϹ²Ê¶
¹ú¼ÒÎÀ½¡Î¯µÈ×éÖ¯ÐÞ¶©ÁË¡¶Ò©Îï´úлøºÍÒ©Îï×÷Óðеã»ùÒò¼ì²â¼¼ÊõÖ¸ÄÏ£¨ÊÔÐУ©¡·Ö¸ÄÏÃ÷È·Ìá³ö£º½¨Òé½øÐÐCYP2C19µÈ»ùÒòµÄ¶à̬ÐÔ¼ì²â£¬Ôö¼ÓPM»ùÒòÐ͸öÌåÂÈßÁ¸ñÀ׵ļÁÁ¿£¬»òÑ¡ÓÃÆäËû²»¾CYP2C19´úлµÄѪС°åÒÖÖƼÁÒ©ÎïÈçÌæ¸ñÈðÂåµÈ¡£
ͼƬÀ´Ô´£ºÒ½¹Ü¾Ö¹ÙÍø
ͼƬÀ´Ô´£º¡¶ÖйúҽѧǰÑØÔÓÖ¾£¨µç×Ӱ棩¡·2017 ÄêµÚ 9 ¾íµÚ 7 ÆÚ
Èý¡¢ÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿Âý²¡¸öÌ廯»ùÒò¼ì²â
ÎÒÃÇ×ñÑÖ¸ÄÏ£¬È«ÏßÉÏÐÂÂý²¡¸öÌ廯»ùÒò¼ì²â£¬ÖÂÁ¦ÓÚ¾«×¼¡¢¸öÌ廯ÓÃÒ©£¬¼õÉÙ²¡»¼²»Á¼·´Ó³£¬ÈÃÿλ»¼ÕßÓÃÉÏ×îºÏÊʵÄÒ©£¬¸üºÃµÄ·þÎñÓÚÂý²¡¹ÜÀí¡£
¼ì²âÄÚÈÝ
4´óÀ࣬21СÀ࣬58ÖÖÒ©Î81¸ö»ùÒòλµã
²úÎïÓÅÊÆ
ÊÊÓÃÈËȺ
³õ´ÎÓÃÒ©µÄ»¼Õß
ÈκιØ×¢¸öÌ廯ÓÃÒ©µÄÈËȺ
¿¼Âǵ÷ÕûÒ©Îï»ò¼ÁÁ¿µÄ»¼Õß
Ò©ÎïÁÆЧ²»¼Ñ»òÓÐÑÏÖز»Á¼·´Ó³µÄ»¼Õß
Ñù±¾ÒªÇó
ÍâÖÜѪ 5ml
ÍÙÒº 2ml
²Î¿¼ÎÄÏ×
[1] ÁõÃ÷²¨£¬Àîï׳壬ÁõÊÀì¿£¬µÈ£®2010 ÄêÖйúÈËȺ¸ßѪѹ¼²²¡¸ºµ£ [J]£®ÖлªÁ÷Ðв¡Ñ§ÔÓÖ¾£¬2014£¬35£¨6£©£º680-683£®
[2] Li Y, Feng X, Zhang M, et al. Clustering of cardiovascular behavioral risk factors and blood pressure among people diagnosed with hypertension: a nationally representative survey in China[J]. Sci Rep, 2016, 6:27627.
ÔÁ¹«Íø°²±¸ 44030602000441ºÅ